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Abstract Treatment partnering is an adherence inter-
vention developed in sub-Saharan Africa. This paper
describes the additional social functions that treatment
partners serve and shows how these functions contribute to
health and survival for patients with HIV/AIDS. Ninety-
eight minimally structured interviews were conducted with
twenty pairs of adult HIV/AIDS patients (N = 20) and
treatment partners (N = 20) treated at a public HIV-care
setting in Tanzania. Four social functions were identiﬁed
using inductive, category construction and interpretive
methods of analysis: (1) encouraging disclosure; (2) com-
bating stigma; (3) restoring hope; and (4) reducing social
difference. These functions work to restore social con-
nections and reverse the isolating effects of HIV/AIDS,
strengthening access to essential community safety nets.
Besides encouraging ARV adherence, treatment partners
contribute to the social health of patients. Social health as
well as HIV treatment success is essential to survival for
persons living with HIV/AIDS in sub-Saharan Africa.
Keywords Treatment partner, treatment assistant  HIV 
HIV/AIDS  Africa  Adherence
Resumen Tratamiento asociarse es una adhesio ´n inter-
vencio ´n desarrollado en el A ´frica subsahariana. Este doc-
umento describe las funciones sociales que el tratamiento
socios servir y muestra co ´mo estas funciones contribuyen a
la salud y la supervivencia para pacientes con VIH/SIDA.
El Noventa y ocho mı ´nimamente estructurada se realizaron
entrevistas con veinte pares de adultos con VIH/SIDA
pacientes (N = 20) y el tratamiento asociados (N = 20)
tratada en un pu ´blico VIH-cuidado en Tanzania. Cuatro
funciones sociales fueron identiﬁcados mediante inductivo,
categorı ´a construccio ´n interpretativa y me ´todos de ana ´lisis:
(1) alentando revelacio ´n; (2) lucha contra el estigma; (3)
restaurar la esperanza; y (4) reducir diferencia social. Estas
funciones trabajar para restablecer las conexiones sociales
y revertir los efectos aislar del VIH/SIDA, fortalecer el
acceso a redes comunitarias de seguridad. Adema ´s alentar
ARV adhesio ´n, el tratamiento socios que contribuyen a la
salud social de los pacientes. La salud Social ası ´ como
tratamiento para el VIH e ´xito es esencial para la supervi-
vencia de personas que viven con el VIH/SIDA in sub-
Saharan Africa.
Introduction
In resource-constrained settings, people rely on family
members, friends and neighbors to help make ends meet [1,
2]. This includes sharing resources necessary for daily
living. Reliance on others is particularly important for
people living with HIV/AIDS, who often need help to
adhere to medications and keep health care appointments.
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retroviral (ARV) adherence and positive treatment out-
comes in resource-scarce environments [3–7]. An ethno-
graphic study conducted in Nigeria, Tanzania, and Uganda
explained ARV adherence success in sub-Saharan Africa as
a function of patients’ desires to fulﬁll social responsibil-
ities and preserve social capital in essential relationships
[8]. Individuals on ARV therapy prioritized adherence by
borrowing transport funds, allocating scarce resources in
favor of treatment, and ‘‘doing without.’’ Help from treat-
ment partners and other family members and friends made
this possible, but helpers expected adherence in return.
Patients adhered to fulﬁll expectations, and position
themselves to continue to beneﬁt from others’ support.
Adherence to ﬁrst-line drug regimens is particularly
important where second-line regimens are not readily
available. In Africa, HIV/AIDS treatment program planners
have used treatment partners for adherence support. Known
by different names in different places (treatment assistants,
or treatment supporters) and varying slightly in speciﬁc
responsibilities, treatment partners (TPs) help individuals
prescribed ARV therapy to adhere to the medications. TPs
may be family members or friends nominated for the role in
response to a clinic recommendation or requirement. As
TPs, these individuals assume a measure of responsibility
for the adherence success of the patient they support.
Treatment partnering overlaps signiﬁcantly with other
forms of adherence and treatment support, but it also dif-
fers in important ways. Unlike directly observed therapy
(DOT) and modiﬁed directly observed therapy (mDOT) for
HIV [9–12], actual observation of pill-taking is not part of
the deﬁnition of treatment partnering, although it may
occur as part of the helping process. TPs also differ from
community health workers in that they are not employees
of, or based at, a clinic or service organization, and are not
paid for their efforts [13–16]. Treatment partners are not
formally trained, nor are they asked by clinicians to per-
form functions (e.g., counseling [17] or home-based care
[18, 19]) other than helping to make sure patients follow
prescribed dosing regimens.
Efforts to measure the impact of treatment partners on
patient clinical outcomes have yielded mixed results. A
study conducted in Jos, Nigeria, showed a beneﬁcial effect
on drug adherence (measured as clinic-based pill counts)
and viral load for participants with patient-selected treat-
ment partners; however, there was no durable effect on
viral suppression [20]. A sub-study designed to examine
the impact of treatment partners on drug resistance showed
no association [21]. A randomized controlled trial of
trained patient nominated treatment supporters providing
partial directly observed antiretroviral therapy in Cape
Town, South Africa, showed no effect on virologic out-
comes but greater CD4 cell count increases at 6-month
follow-up visits [22]. A randomized controlled trial
investigated the impact of treatment support on adherence
and clinic attendance in Uganda. The supported patients
did not differ from controls in mean adherence (98.3–99%
vs. 94.2–98.3%) or in appearing on time for clinic
appointments, but they were four times more likely to
achieve optimal adherence (C95%) (P = 0.027) [23]. A
qualitative study in South Africa identiﬁed moral authority
as a key ingredient of treatment support, making it possible
for supporters to inﬂuence health-related decisions [24].
A growing body of U.S. and international research
investigating various forms of social support for HIV/AIDS
is relevant to understanding treatment partners. Interven-
tions aimed at providing social support through peers
(other individuals living with HIV/AIDS) have been shown
to impact risk behaviors, and knowledge and attitudes
toward HIV [25–27]. A number of approaches to providing
couples-based support for adherence and HIV prevention
have also been examined [28–35].
Overall, previous research on both treatment partners
and other interpersonal interventions has targeted behav-
ioral and biologic outcomes. In contrast, this analysis
highlights social consequences of treatment partnering and
its signiﬁcance for the health and well being of individuals
living with HIV/AIDS in sub-Saharan Africa.
Methods
A Grounded Theory Approach
This qualitative study used a grounded theory approach.
Grounded theory, ﬁrst described by Glaser and Straus in
1967, refers to systematic generation of theory from
qualitative data. Analysis proceeds inductively, beginning
with coding, then using coded data to form concepts and
categories. Theory is generated interpretively by arranging
the categories to propose a general explanatory account.
Study Design and Setting
This patient-centered, qualitative interview study took
place at Amana District Hospital, a public HIV-treatment
setting in Dar es Salaam, Tanzania. Data were collected
from 2006 to 2008. Of 9,500 patients in the HIV clinic,
5,300 were prescribed ARVs at the time of the study.
ARVs were provided through the President’s Emergency
Plan for AIDS Relief (PEPFAR).
Sampling and Recruitment
Twenty adults receiving care and treatment for HIV/AIDS
at Amana Hospital and their TPs (N = 40 individuals)
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123made up the sample for this analysis. Patient participants
were randomly selected from a larger population of adults
meeting the following inclusion criteria: (1) age 18 years
or older; (2) prescribed antiretroviral therapy for no fewer
than six and no more than 12 months at the time of sam-
pling; and (3) residence within 20 km of Amana District
Hospital. To identify potential treatment partner partici-
pants, patients were asked to name ‘‘someone who assisted
them in their efforts to take antiretroviral medications.’’
Treatment partners were part of the clinic’s program of
support for ARV adherence.
Patient participants were recruited at the clinic during
routine follow-up visits. Research assistants approached
eligible individuals to describe the study and to extend an
invitation to participate. Potential TP participants were
initially contacted by patient participants, who presented
the study using an IRB-approved script and requested
permission for subsequent contact by research staff.
The research was approved by the institutional review
boards at Harvard Medical School (Boston, Massachusetts,
United States) and Muhimbili University of Health and
AlliedSciences(DaresSalaam,Tanzania).Writteninformed
consent was obtained from all participants.
Data Collection
Data were collected through in-person qualitative inter-
views as part of a three-country study of social inﬂuences
on adherence to ARVs. Local researchers trained in qual-
itative data collection techniques conducted interviews.
Interviews were minimally structured, meaning that core
topics, but not speciﬁc questions, were pre-designated. This
approach ensured the same broad areas were covered in
each interview, while allowing unanticipated material to
emerge. Core topics for patient interviews included: [1]
speciﬁc experiences of taking ARVs (e.g., stories of the
most recent dose taken and the most recent dose missed);
[2] clinic visits; and [3] help received from TPs. Core
topics for treatment partner interviews included: [1] types
of help provided; [2] feelings about being a treatment
partner; and [3] perceptions of the impact of the help
provided.
The goal of the interviews was to elicit data on expe-
riences of adherence from patient and treatment partner
perspectives. Interviews were conducted in homes or at
other locations of the interviewees’ choosing outside of the
clinic. Conducting the interviews in locations where the
conversations could not be overheard protected privacy.
Interviewees had the option of conducting the interview in
the local language (Kiswahili) or in English. Interviews
were audio-recorded with permission and averaged about
an hour in length. Patients received compensation in the
form of a small stipend and, whenever applicable, reim-
bursement for transportation.
Multiple interviews were conducted with each patient
and treatment partner to allow for elaboration of unantic-
ipated topics of emerging signiﬁcance. Patients were
interviewed three times each (Total Patient Interviews =
60). Thirty-eight interviews were conducted with the 20
TPs. (Total interviews = 98).
Data Preparation
Shortly after the completion of each interview, interviewers
produced a detailed write-up in English, using the audio
recording and written notes to ensure accuracy and com-
pleteness. The interviews were written up as ‘‘stream-lined’’
transcripts. ‘‘Stream-lined’’ transcripts are verbatim verbal
accounts that include interviewer questions and interviewee
responses, while excluding non-essential content (e.g., hesi-
tations, repetition of phrases). This approach to transcription
capturesdetailandpreservestheexactwordsofinterviewees.
The transcripts were produced in English (without ﬁrst tran-
scribing into the local language), and contained a section in
which the interviewer added relevant contextual details and
impressions not captured in the transcript.
Data Analysis
Analysis was aimed at identifying and representing the
functions of TPs using an inductive approach to the con-
structionofdescriptivecategories[36,37].First,contentthat
related to ways TPs helped patients was retrieved from the
data. Relevant sections of text were identiﬁed, copied, and
grouped according to the type of assistance provided. These
sections of text were then reread to characterize various
forms of help. The data were reorganized in terms of these
characterizations to produce an initial category set. Each
category forming the set was named, deﬁned, and illustrated
through interview excerpts. The set was reﬁned, revised,
speciﬁed, and elaborated through successive returns to the
data in which additional sections of relevant text were
extracted. Ultimately, categories were grouped into larger
thematicdomainstermedisolationandintegration,toforma
narrative explanation of the social functions TPs fulﬁll
Results
Study Participants
Patients: Two-thirds (68%) of patient participants were
female; they averaged 40 years of age. Slightly more than
half (53%) were Christian; slightly fewer than half were
Muslim (47%). Average number of years of education was
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1238.5. All patients reported 100% adherence, assessed using
the Adult AIDS Clinical Trials Group (AACTG) 3-day self
report measure [38]. Mean reported monthly income was
121,290 Tanzanian Shillings (approximately $82 USD),
shared by an average of 5.5 people. Mean amount of
money available for or spent on food each day was 3,383
Tanzanian Shillings ($2.29 USD); almost half (43%) of
patients reported that the family income had been spent
entirely on food in the previous month.
Treatment partners: Slightly more than half (55%) of TP
participants were female; average age of the group was 41.
Fifty-three percent of TPs were Muslim; 47% were
Christian. Average number of years of education was 7.4.
Participating treatment partners’ were related to patients as:
[1] spouses (30%), [2] siblings (25%), [3] parents (20%),
[4] adult children (5%), and [5] extended family members
(5%). Fifteen percent reported another type of relationship.
The majority of treatment partners (65%) shared a resi-
dence with the patient. The remainder lived a short walk
away.
Qualitative Results
Qualitative results are organized into three sections corre-
sponding to the major categories constructed through the
inductive analysis. Together, the sections present the logic
and supporting data for our central argument: in addition to
supporting adherence, TPs work to restore the social health
of patients living with HIV/AIDS.
Community As Resource
The interviews depict the daily lives of patient participants
as revolving around efforts to cope with economic scarcity.
Most of each day was spent working to obtain essential
goods such as food and water. Other important resources,
such as clothing, medications, health services, transporta-
tion and housing, were a lower priority. Routine household
tasks, e.g. food preparation and cleaning, were labor
intensive, draining time and energy. To sustain themselves
in poverty, people relied on others for help.
Who were these helpers? For study participants, helpers
included family, neighbors, friends, people with whom
they exchanged goods and services, work colleagues and
acquaintances from church/mosque or health clinics. These
people were their community, the core group they counted
on to make ends meet.
Communities provide help in a number of ways, one of
the most signiﬁcant of which is lending money. Patient
participants routinely borrowed money from friends and
family to meet urgent needs, such as food, medications and
transportation to the health clinic. They also borrowed from
lending groups, informal organizations in which individu-
als pooled money and then borrow from the pool when
needed. Providing needed funds is one of many ways
communities function as resources in settings of economic
scarcity. To continue to draw upon community as resource,
individuals must be in good standing in the social group.
Isolating Effects of HIV/AIDS
Isolation and Disclosure (and Non-Disclosure)
HIV/AIDS erodes social standing and isolates individuals
from the communities they depend on. The risk of dis-
closure lies in loss of social standing and resulting isola-
tion. One patient participant put it this way:
‘‘I don’t see the reason to tell people. If they have run
out on me with regular sickness, not knowing my
HIV serostatus, if I tell them [I am HIV-positive] they
may run forever.’’
Isolation from the community means being denied access
to needed community resources. As ﬁnancial borrowers,
for example, HIV ? persons are seen as poor risks.
Potential lenders fear they may not remain healthy long
enough to earn the money to repay a loan. In the words of
one interviewee:
‘‘They see it as useless to assist someone who has a
shorter time to live. It’s like wasting money. Why
assist someone who is going to die?’’
HIV ? persons resist disclosure to avoid isolation and
preserve access to community resources; however, non-
disclosure can also be isolating. Not disclosing means not
being able to ask for help with problems arising from HIV/
AIDS. It means hiding medications and clinic visits. Some
study participants abandoned their jobs in order to conceal
their HIV status. One interviewee explained her decision to
stop working this way:
‘‘I thought that people would know my HIV status
when I have illnesses regularly and am out of the
ofﬁce several times.’’
Non-disclosure may reduce the threat of being stigmatized,
but at the cost of weakening essential connections to
others.
Demoralization as Isolation
HIV/AIDS is demoralizing. Patient participants in this
study spoke of the sadness, discouragement, and anxiety of
being HIV ? . They described fear of death, and loss of a
sense of purpose in life. In the words of one:
AIDS Behav (2012) 16:1308–1315 1311
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had for my future plans was useless to me now. I
didn’t feel like continuing to work, because I thought
at any time I am going to die. There is no meaning to
work while I suspect to die at any time.’’
For some, the demoralization of HIV/AIDS led to thoughts
of suicide. One individual described suicide as a reasonable
alternative to enduring the stigma of HIV/AIDS.
‘‘It is better to die with malaria, and for people to say
I died from malaria. Now with HIV, I desire for
committing suicide.’’
Demoralization fuels isolation by creating a desire for
separation and making daily functioning more difﬁcult.
Restoring Social Connection: How Treatment
Partners Help
Treatment partner participants in this study included fam-
ily, neighbors, friends, people with whom patients
exchanged goods and services, workmates and acquain-
tances from churches, mosques, and health clinics. Their
designated clinical function was to help with adherence to
ARVs. Patient participants cited many forms of adherence
help. TPs offered in-person, phone, and text message
reminders. They made sure patients had food, to improve
medication tolerance. One treatment partner described her
considerable efforts to deliver food to a patient in secret so
the patient would not be obliged to share it with family
members. TPs also helped patients to obtain essential non-
food items, such as clothes and cleaning supplies. They
reminded patients to attend clinic appointments, often
providing or funding transportation themselves.
In addition to promoting ARV adherence, TPs inter-
vened to reverse the isolating effects of HIV/AIDS and
strengthen social connectedness. Four ways in which TPs
acted to enhance social connection for patients were evi-
dent in the study data: [1] encouraging disclosure, [2]
combating stigma, [3] restoring hope, and [4] reducing
‘‘social difference.’’ These four connecting functions are
presented in turn below.
Encouraging Disclosure
Non-disclosure of HIV status is isolating, as it precludes
seeking and/or receiving needed support from sympathetic
others. Recognizing this, TPs encouraged disclosure by
pointing to the support that might ensue. They reminded
patients, for example, of the resources, prayers and
encouragement that might be forthcoming from religious
afﬁliates. Disclosure re-connects HIV-infected persons to
their family and friends by opening the door to commu-
nication about HIV/AIDS.
Combating HIV-Related Stigma
TPs actively worked to combat the effects of HIV-related
stigma. They intentionally interacted with people known to
be HIV positive in public, for example, sharing meals to
discredit the myth that common utensils can transmit the
virus. Another reported tactic was to publicly criticize
individuals who stigmatize persons with HIV/AIDS. One
patient participant explained how her treatment partner
‘‘warns people who stigmatize the HIV people’’ by telling
them:
‘‘You know HIV now is common. The sick ones are
healthier than the healthier people. Nowadays if you
stigmatize the HIV patient you will be taken into
court. It’s not good to stigmatize the HIV people.’’
Efforts to minimize stigma strengthen relationships by
building solidarity with patients.
Restoring Hope
Patients characterized demoralization as ‘‘losing hope.’’
Treatment partners worked to restore hope, or ‘‘give hope,’’
as they put it, through a number of deliberate strategies.
They countered feelings of loneliness by spending time
with patients. They reminded them that they were not
alone. They counseled faith in God. TPs also helped create
a sense of possibility for patients by citing the potential for
change: they could expect to live in good health if they
took their medications as prescribed and otherwise
followed directions from health care professionals. The
following excerpts illustrate:
‘‘He [patient] lost hope when he was very sick. He
thought he couldn’t be healed. I gave him hope by
insisting that he follow the instructions given at the
clinic.’’
‘‘I gave her an example of some people who have
been on ARV medication and they have shown
positive health progression to give her courage.’’
Reducing Social Difference
HIV/AIDS increases poverty by interfering with income
generation. Interference stems both from poor health and
from time diverted from income generating activities. One
way impoverishment becomes visible is through deterio-
ration in number and quality of possessions. When clothing
wears out and cannot be replaced, for example, it sig-
nals social difference. Individuals wearing torn and dirty
1312 AIDS Behav (2012) 16:1308–1315
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Recognizing this, TPs take steps to erase evidence of social
difference. For example, they may buy a patient new
clothes. The following citations illustrate:
‘‘I [buy clothes for the patient] so she can see she’s a
normal person, to make her feel normal like other
people. Once we are not assisting her in that way, she
will feel stigmatized.’’
‘‘I assist her with clothes to make her feel like other
people and not feel she is neglected because of her
HIV status.’’
Thus we see how in this low-resource setting, the
community serves as an essential resource. Being able to
rely on the community to help obtain goods and complete
daily tasks is critical to survival. HIV/AIDS isolates indi-
viduals from the community. Treatment partners restore
social connections and reintegrate persons living with HIV/
AIDS into the community.
Discussion
In addition to promoting medication adherence, TPs play
an important social role in the lives of the patients they
help. They encourage disclosure, combat stigma, restore
hope, and reduce social difference. All of these are ways of
‘‘normalizing’’ HIV/AIDS – of reversing social isolation
and reinstating connections to others.
As a strategy for adherence support, TPs are a natural ﬁt
for social settings where reliance on others is the norm. The
treatment partner model formalizes existing helping rela-
tionships and uses them to promote treatment success. The
socially integrating aspects of treatment partnering have
not previously been made explicit.
Social embeddedness promotes health [39–41] for per-
sons living with HIV/AIDS [42]. In settings of poverty,
strong interpersonal relationships are needed for survival.
Where resources are scarce, reliance on ‘‘community safety
nets’’ [43] helps to bridge inevitable gaps. In strengthening
social connectedness, TPs ensure patients’ continued
access to safety nets.
Though suggestive, the small amount of experimental
evidence evaluating the impact of TPs on clinical outcomes
does not clearly demonstrate the superiority of the inter-
vention compared to standard controls. Multiple studies
have revealed short-term positive effects, which dimin-
ished over time [20–22]. Where helping is the norm, failure
to detect large effects may be a function of levels of
informal support in the control group.
This analysis supports previous claims about the
importance of qualitative methods in contributing to
research on treatment interventions for HIV/AIDS [44].
The qualitative design included multiple perspectives
(including those of TPs) in the study sample, and adopted
an inductive approach to data collection and analysis. As a
result, we were able to uncover new functions of an
adherence intervention and explain their relevance to
health and survival for persons living with HIV/AIDS in
sub-Saharan Africa.
We acknowledge the limitations of this work. As a quali-
tative analysis, it does not quantitatively assess the impact of
treatment partnering upon clinical or other outcomes. The
relative contributions of speciﬁc connecting functions cannot
bequantitativelyestimated.Thesampleissmallandreﬂectsa
single geographic location and a single treatment program.
Qualitative research does not aim for generalizability; hence
broader inferences cannot be drawn from the results.
Conclusion
HIV/AIDS has profound social and health consequences,
isolating HIV ? persons from social reference groups. TPs
are charged with promoting ARV adherence, but they pro-
vide important social help as well. This analysis details the
ways in which TPs rebuild social ties and restore the social
standing of HIV ? persons in their communities. Good
social standing means help from others will be available
when needed. Where resources are otherwise scarce, help
from others is critical for coping with adversity. In estab-
lishing treatment partners as an adherence intervention,
African treatment program planners may have enhanced the
social and physical health of persons with HIV/AIDS.
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